01:03 AM EDT, 09/22/2026 (MT Newswires) -- ABL Texcell Diagnostics (ABLD.PA) signed a non-binding letter of intent to acquire Vela Operations Singapore and Vela Diagnostics USA. The LoI was signed together with the molecular diagnostics firm's parent company, Advanced Biological Laboratories, and Vela Group's parent, VDH Holding, according to a Monday release. ABL said the transaction will expand its footprint into the Asia-Pacific region and the US. The deal is subject to due diligence, final agreements and regulatory approvals.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.